News & Press Releases

All
News & Press Releases
All
Events & Presentations

Smart Immune Announces Oral Presentation of Cell Fate Plasticity Data of its T-cell Progenitor-Based Therapy Platform (ProTcell™) at ASGCT 2022

May 20, 2022

Smart Immune Wins  Best Therapeutic Innovation and Oncology Upward Investmeant Awards at MATWIN

May 19, 2022

Deep molecular characterization of ex vivo generated T cell progenitors open perspectives for the development of new therapies

May 3, 2022

Smart Immune Announces Research Collaboration with Memorial Sloan Kettering Cancer Center (MSKCC) to Expedite Development of a Next Generation CAR-T Through its Long Lasting, Exhaustion-Free CAR ProTcell™ Platform

December 9, 2021

Smart Immune Announces Acceptance of Two Abstracts Covering Preclinical Research and Clinical Data at the American Society of Hematology

November 5, 2021

Smart Immune Receives IRB Approval For Phase 1/2 Clinical Trial of Proprietary Allogeneic T-cell Product Smart-101 (ProTcell™) for AML and ALL.

October 13, 2021